随着心脏磁共振技术在临床上的广泛应用,提升心血管影像和临床医生的专业技能变得尤为关键。心脏磁共振培训班将于2024年7月20日~21日在清华大学第一附属医院(北京华信医院)举办,请关注下方海报,扫描二维码查看详细信息。
本次培训班,特邀新加坡国家心脏中心CMR中心主任、临床科学家Calvin Chin教授做主题为“运动CMR中卧式核磁功率车的临床应用”的讲座。
Calvin Chin教授是新加坡国家心脏中心心脏病学高级顾问,致力于研究高血压心脏病等心脏代谢疾病的心脏重塑,将运动压力CMR技术转化为临床实践。
-
新加坡健保集团杜克-新加坡国立大学心血管科学学术临床项目研究执行委员会
-
新加坡医学院FELLOW
-
英国皇家医师学院FELLOW
Calvin Chin教授发表的文献
• Paradoxical higher myocardial wall stress and increased cardiac remodeling despite lower mass in females. Phua AIH, Le TT, Tara SW, DeMarvao A, Duan J, Toh DF, Ang B, Bryant JA, O’Regan DP, Cook SA, Chin CWL. J Am Heart Assoc. 2020; 9(4):e014781
• Extracellular myocardial volume in patients with aortic stenosis. Everett RJ, Treibel TA, Fukui M, Lee H, Rigolli M, Singh A, Bijsteveld P, Tastet L, Musa TA, Dobson L, Chin C, Captur G, Om SY, Wiesemann S, Ferreira VM, Peichnik SK, Schulz-Menger J, Schelbert EB, Clavel MA, Newby DE, Myerson SG, Pibarot P, Lee S, Cavalcante JL, Lee SP, McCann GP, Greenwood JP, Moon JC, Dweck MR. J Am Coll Cardiol. 2020; 75(3):304-316
• Feasibility to perform T2* mapping postcontrast administration in reperfused STEMI patients for the detection of intramyocardial hemorrhage. Bulluck H, Chowdhury N, Lim MX, Allen JC, Bryant JA, Chan MY, Chan MHH,Chin CWL, Ho HH, Lim ST, Tan ST, Tan JW, Wong PE, Yeo KK, Cook SA, Hausenloy DJ. J Magn Reson Imaging. 2020; 51(2):644-645
• Wu D, Dou J, Chai X, Bellis C, Wilm A, Shih CC, Soon WWJ, Bertin N, Lin CB, Khor CC, DeGiorgio M, Cheng S, Bao L, Karnani N, Hwang WYK, Davila S, Tan P, Shabbir A, Moh A, Tan EK, Foo JN, Goh LL, Leong KP, Foo RSY, Lam CSP, Richards AM, Cheng CY, Aung T, Wong TY, Ng HH;SG10K Consortium (Chin CWL), Liu J, Wang C. Large-scale whole-genome sequencing of three diverse Asian populations in Singapore. Cell. 2019; 179(3):736-749
• Teo JX, Davila S, Yang C, Hii AA, Pua CJ, Yap J, Tan SY, Sahlen A,Chin CWL, Teh BT, Rozen SG, Cook SA, Yeo KK, Tan P, Lim WK. Digital phenotyping by consumer wearables identifies sleep-associated markers of cardiovascular disease risk and biological ageing. Commu Biol. 2019; 2(1):361
• Plasma desmosine and abdominal aortic aneurysm diseaseMordi IR, Forsythe RO, Gellatly C, Iskandar Z, McBride OM, Saratzis A, Chambers R, Chin C, Brown MJ, Newby DE, Lang CC, Huang JTJ, Choy AM. J Am Heart Assc. 2019; 8(20):e013743
• Sex differences in left ventricular remodelling, myocardial fibrosis and mortality after aortic valve replacementSingh A, Musa TA, Treibel TA, Vassilou VS, Captur G,Chin C, Dobson LE, Pica S, Loudon M, Mailey T, Riggoli M, Foley JRJ, Bijsterveld P, Law GR, Dweck MR, Myerson SG, Prasad SK, Moon JC, Greenwood J, McCann GP. Heart. 2019; 105(23):1818
• Impact of systemic vascular risk factors on the choriocapillaries using optical coherence tomography angiography in patients with systemic hypertension. Chua J,Chin CWL, Tan B, Wong SH, Devarajan K, Le TT, Ang M, Wong TY, Schmetterer L. . Sci Rep. 2019; 9(1):5819
• Impact of hypertension on retinal microvascular changes using optical coherence tomographic angiography. Chua J,Chin C, Hong J, Chee ML, Le TT, Ting DSW, Wong TY, Schmetterer L. J Hypertens. 2019; 37(3):572
• Inter-relationship between ageing, body mass index, diabetes, systemic blood pressure and intraocular pressure in Asians: 6-year longitudinal study. Chua J, Chee ML,Chin CWL, Tham YC, Tan N, Lim SH, Aung T, Cheng CY, Wong TY, Schmetterer L. Br J Ophthalmol. 2019; 103(2):196-202
• Incidence and predictors of left ventricular thrombus by cardiovascular magnetic resonance in acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention: a meta-analysis. Bulluck H, Chan MHH, Paradies V, Yellon RL, Ho HH, Chan MY,Chin CWL, Tan JW, Hausenloy DJ. J Cardiovasc Magn Reson 2018; 20:72
• High-sensitivity cardiac troponins in cardio-healthy subjects: a cardiovascular magnetic resonance imaging study. Aw TC, Huang WT, Le TT, Pua CJ, Ang B, Phua SK, Yeo KK, Cook SA,Chin CWL. . Sci Rep. 2018; 18(8):15409
• Myocardial scar and mortality in severe aortic stenosis: Data from the BSCMR Valve Consortium. Musa T, Treibel T, Vassilou V, Captur G, Singh A,Chin C, Dobson L, Pica S, Loudon M, Malley T, Rigolli M, Foley JR, Bijsterveld P, Law GR, Dweck M, Myerson S, McCann G, Prasad S, Moon JC, Greenwood J. Circulation. 2018; 138:1935
• Progression of hypertrophy and myocardial fibrosis in aortic stenosis: a multicenter cardiac magnetic resonance study. Everett RJ, Tastet L, Clavel MA,Chin CWL, Capoulade R, Vassiliou VS, Kwiencinski J, Gomez M, van Beek EJR, White AC, Prasad SK, Larose E, Tuck C, Semple S, Newby DE, Pibarot P, Dweck MR. Circ Cardiovasc Imaging. 2018; 11:e007451
• Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genes. Walsh R, Buchan R, Wilk A, John S, Felkin LE, Thomson KL, Chiaw TH, Chin CW, Pua CJ, Raphael C, Prasad S, Barton PJ, Funke B, Watkins H, Ware JS, Cook SA. Euro Heart J 2017; 38(46):3461-3468.
• Cai J, Bryant JA, Le TT, Su B, de Marvao A, O’Regan DP, Cook SA, Chin CW. Fractal analysis of left ventricular trabeculations is associated with impaired myocardial deformation in healthy Chinese. J Cardiovasc Magn Reson 2017; 19:102
• Adverse prognosis associated with asymmetric myocardial thickening in aortic stenosis. Chin CW, Kwiencinski J, Everett RJ, White AC, Semple S, Yeung E, Jenkins WJ, Shah AS, Koo M, Mirsadraee S, Lang CC, Mills N, Prasad SK, Jansen MA, Japp AG, Newby DE, Dweck MR. Eur Heart J Cardiovasc Imaging 2018; 19(3):347-356
• Lim WK, Davila S, Teo JX, Yang C, Pua CJ, Blocker C, Lim JQ, Yap J, Tan SY, Sahlen A,Chin CW, Teh BT, Rozen SG, Cook SA, Yeo KK, Tan P. Beyond fitness tracking: the use of consumer grade wearable data from normal volunteers in cardiovascular and lipidomics research. PLoS Biol. 2018; 16:e2204285
• Effects of Aortic Valve Replacement on Severe Aortic Stenosis and Preserved Systolic Function: Systematic Review and Network Meta-analysis. Zheng Q, Djohan AH, Lim E, Ding ZP, Ling LH, Shi L, Chan ES,Chin CWL. Sci Rep. 2017; 11(7):5092
• Novel Index of Maladaptive Myocardial Remodeling in Hypertension. Goh VJ, Le TT, Bryant J, Wong JI, Su B, Lee CH, Pua CJ, Sim CPY, Ang B, Aw TC, Cook SA,Chin CWL. Circ Cardiovasc Imaging 2017; 10(9):e006840
• Myocardial Fibrosis and Cardiac Decompensation in Aortic Stenosis. Chin CW, Everett R, Kwiecinski J, Vesey A, Yeung E, Esson G, Jenkins W, Koo M, Mirsadraee S, White A, Japp A, Prasad S, Semple S, Newby D, Dweck M. JACC Cardiovasc imaging 2017; 10(11):1320-1333
• Disparity Between Indications for and Utilization of Implantable Cardioverter Defibrillators in Asian Patients With Heart Failure. Chia YMF, Teng TK, Tan ESJ, Tay WT, Richards MA,Chin CWL, Shimizu W, Park SW, Hung CL, Ling LH, Ngarmukos T, Omar R, Siswanto BB, Narasimhan C, Reyes EB, Yu CM, Anand I, MacDonald MR, Yap J, Zhang S, Finkelstein EA, Lam CSP. Circ Cardiovasc Qual Outcomes 2017; 10(11):e003651
• Cardiac myosin-binding protein C is a novel marker of myocardial injury and fibrosis in aortic stenosis. Anand A,Chin C, Shah ASV, KwieciÅ Ski J, Vesey A, Cowell J, Weber E, Kaier T, Newby DE, Dweck M, Marber MS, Mills NL. Heart 2017;104:1101-1108.
• Titin-truncating variants affect heart function in disease cohorts and the general population. Schafer S, de Marvao A, Adami E, Fiedler LR, Ng B, Khin E, Rackham OJ, van Heesch S, Pua CJ, Kui M, Walsh R, Tayal U, Prasad SK, Dawes TJ, Ko NS, Sim D, Chan LL, Chin CW, Mazzarotto F, Barton PJ, Kreuchwig F, de Kleijn DP, Biffi C, Tee N, Rueckert D, Schneider V, Faber A, Regitz-Zagrosek V, Seidman JG, Linke WA, Kovalik JP, O’Regan D, Ware JS, Hubner N, Cook SA. Nat Genet. 2017;49:46-53
• Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genes. Walsh R, Buchan R, Wilk A, John S, Felkin LE, Thomson KL, Chiaw TH, Chin CW, Pua CJ, Raphael C, Prasad S, Barton PJ, Funke B, Watkins H, Ware JS, Cook SA. Eur Heart J. 2017 Jan 11 [Epub ahead of print].
• Assessing exercise cardiac reserve using real-time cardiovascular magnetic resonance. Le TT, Bryant JA, Ting AE, Ho PY, Su B, Teo RC, Gan JS, Chung YC, O’Regan DP, Cook SA, Chin CW. J Cardiovasc Magn Reson 2017;19(1):7.
• Adverse prognosis associated with asymmetric myocardial thickening in aortic stenosis. Chin CW, Kwiencinski J, Everett RJ, White AC, Semple S, Yeung E, Jenkins WJ, Shah AS, Koo M, Mirsadraee S, Lang CC, Mills N, Prasad SK, Jansen MA, Japp AG, Newby DE, Dweck MR. Eur Heart J Cardiovasc Imaging. 2017 Mar 30 [Epub ahead of print].
• Stress cardiovascular magnetic imaging. Le TT, Huang W, Bryant JA, Cook SA, Chin CW. Expert Rev Cardiovasc. Ther. 2017;15:181-189. (Review)
• Gender differences in native myocardial T1 in a healthy Chinese volunteer cohort. Bulluck H, Bryant JA, Tan JZ, Go YY, Le TT, Tan RS, Lim TK, Tang HC, Lath N, Low AS, Chin CW, Cook SA, Hausenloy DJ. Cardiovasc Imaging Asia 2017 Mar 30 [Epub ahead of print].
• A clinical risk score of myocardial fibrosis predicts adverse outcomes in aortic stenosis. Chin CW, Messika-Zeitoun D, Shah ASV, Lefevre G, Bailleul S, Yeung ENW, Koo M, Mathieu T, Semple SI, Mills NL, Vahanian A, Newby DE, Dweck MR. Eur Heart J. 2016;37:713-723.
• T1 characteristics of interstitial pulmonary fibrosis on 3T MRI – a predictor of early interstitial change? Mirsadraee S, Tse M, Kershaw L, Semple S, Schembri N, Chin C, Murchison JT, Hirani N, van Beek EJ. Quant Imaging Med Surg. 2016;6(1):42-49.
• The role of cardiac biochemical markers in aortic stenosis. Chin CW, Djohan AH, Lang CC. Biomarkers. 2016;21(4):316-327.
• Paradoxical low gradient aortic stenosis: the HFpEF of aortic stenosis. Chin CW, Ding ZP, Lam CSP, Ling LH. J Am Coll Cardiol. 2016;67(20):2447-2448.
• Cardiovascular magnetic resonance assessment of the heart and aorta in Chinese at 3T. Le TT, Tan RS, De Deyn M, Goh E, Han Y, Leong B, Cook SA, Chin CW. J Cardiovasc Magn Reson. 2016;18(1):21.
• Chest pain with a blue hand – simultaneous coronary and left subclavian artery thrombosis. Chin CY, Chin CW, Chiam P, Tan RS. AsiaIntervention. 2016.
• Myocardial fibrosis and cardiac decompensation in aortic stenosis. Chin CW, Everett R, Kwiecinski J, Vesey A, Yeung E, Esson G, Jenkins W, Koo M, Mirsadraee S, White A, Japp A, Prasad S, Semple S, Newby D, Dweck M. JACC Cardiovasc Imaging. 2016 Dec 21 [Epub ahead of print]
• Paradoxical low-flow low-gradient aortic stenosis: advanced severe disease, a new entity or a progression of disease? Chin CW. Heart 2015;101:1079.
• Valvular (18)F-fluoride and (18)F-fluorodeoxyglucose uptake predict disease progression and clinical outcome in patients with aortic stenosis. Jenkins WS, Vesey AT, Shah AS, Pawade TA, Chin CW, White AC, Fletcher A, Cartlidge TR, Mitchell AJ, Pringle MA, Brown OS, Pessotto R, McKillop G, Van Beek EJ, Boon NA, Rudd JH, Newby DE, Dweck MR. J Am Coll Cardiol. 2015;66(10):1200.
(可下拉查看,了解更多)
核磁功率车并不是大家日常所熟悉的核磁共振(MRI)设备本身,而是一种在MRI检查过程中,专门用于提供精确运动负荷刺激的设备,通过运动促使循环系统(心脏、血管等)产生生理性应激,打破循环系统的稳态,客观的反映出循环系统在压力负荷下的功能状态。
核磁功率车已广泛应用于心血管疾病的诊断和评估中,特别是在先天性心脏病、心力衰竭、冠心病等领域。通过使用核磁功率车,医生可以更准确地评估患者的心脏功能和血流动力学状态,为患者提供更有效的治疗方案。
核磁功率车通过电磁涡流制动系统来实现对运动负荷的精确控制。这种制动系统能确保设备在运行过程中提供稳定且可调整的运动负荷,以满足不同检查需求。
核磁功率车
核磁功率车采用特殊设计和材料,确保在高磁场环境中正常工作,而不会干扰MRI设备的正常运行。
与药物应激测试相比,使用核磁功率车进行运动应激测试可以避免药物可能引起的副作用和不良事件,为患者提供更安全的检查方式。
通过核磁功率车提供的运动负荷刺激,医生可以获取准确的检查结果,提高心脏疾病的诊断准确性。
通过核磁功率车提供的运动负荷刺激,医生可以获取准确的检查结果,提高心脏疾病的诊断准确性。
如果您对心脏磁共振技术感兴趣,欢迎报名参加本次心脏磁共振培训班,与国内外专家一起交流,获取更多专业知识。
如您对我们的文章感兴趣,转载文章请注明来源。
特别提示:“普康科健”微信公众号为您提供康复医学、体育科学和体质健康等领域的知识和产品信息,在撰写和汇编文章的过程中,我们进行科学来源追查,尽可能保证其真实性、科学性和权威性。文章中提供的信息仅供您参考,如您发现文章中存在任何错误,请及时告知我们,感谢您的支持与理解。